Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: Results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
Coronary Artery Disease
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Increasing values of the BIAS score generated by both MRI and SPECT corresponded to the increasing prevalence of CAD and MACE. The BIAS-augmented detection of ischemia better predicted MACE compared with the Original reading for the MPI data for both MRI and SPECT.